banner2

Getting started
Dasatinib Intermediate

Dasatinib Intermediate - China Manufacturers, Suppliers, Factory

Dasatinib Intermediate, , , ,. The product will supply to all over the world, such as Europe, America, Australia,, ,, .

Related Products

Moc-L-Valine CAS 74761-42-5 Factory Shanghai Ruifu Chemical Co., Ltd. www.ruifuchem.com — Moc-L-Valine CAS 74761-42-5 Assay ≥98.0% (HPLC) Ledipasvir Intermediate
Read More

4,4'-Bis(2-Bromoacetyl)biphenyl CAS 4072-67-7 Factory Shanghai Ruifu Chemical Co., Ltd. www.ruifuchem.com — 4,4'-Bis(2-Bromoacetyl)biphenyl CAS 4072-67-7 Daclatasvir Dihydrochloride Intermediate Purity >98.0% (HPLC)

Daclatasvir Intermediate CAS 1007882-23-6 Factory Shanghai Ruifu Chemical Co., Ltd. www.ruifuchem.com — Daclatasvir Dihydrochloride Intermediate CAS 1007882-23-6 Purity >98.0% (HPLC)

Apixaban Intermediate CAS 545445-44-1 Factory Shanghai Ruifu Chemical Co., Ltd. www.ruifuchem.com — Apixaban Intermediate CAS 545445-44-1 Purity >98.0% (HPLC)

N-(4-Cyanophenyl)glycine CAS 42288-26-6 Factory Shanghai Ruifu Chemical Co., Ltd. www.ruifuchem.com — N-(4-Cyanophenyl)glycine CAS 42288-26-6 Dabigatran Etexilate Mesylate Intermediate Purity >99.0% (HPLC)

Dabigatran Etexilate Intermediate CAS 212322-56-0 Factory Shanghai Ruifu Chemical Co., Ltd. www.ruifuchem.com — Dabigatran Etexilate Intermediate CAS 212322-56-0 Purity >99.0% (HPLC)

(R)-N-Despropyl Pramipexole CAS 106092-11-9 Factory Shanghai Ruifu Chemical Co., Ltd. www.ruifuchem.com — (R)-N-Despropyl Pramipexole CAS 106092-11-9 Pramipexole Intermediate Purity >99.0% (HPLC)

banner1

Top Selling Products

Related Blog
Reviews

Focus on Cross Border Integration of Biomedicine and Chemical Materials, October 15, 2021

Focus on Cross Border Integration of Biomedicine and Chemical Materials: New Opportunities, New Technologies and New Models This forum focuses on the interdisciplinary and cutting-edge technologies...
Sodium Salicylate CAS 54-21-7 EP11.0 Standard

SODIUM SALICYLATE Natrii salicylas C7H5NaO3 Mr 160.1 [54-21-7] DEFINITION Sodium 2-hydroxybenzenecarboxylate. Content: 99.0 per cent to 101.0 per cent (dried substance). CHARACTERS Appeara...
The third Guangdong-Hong Kong-Macao Greater Bay Area Pharmaceutical Innovation Technology and Market Access Summit forum November 19 to 21, 2021

The third Guangdong-Hong Kong-Macao Greater Bay Area Pharmaceutical Innovation Technology and Market Access Summit forum November 19 to 21, 2021 As the world’s second largest medical market, ...
The 19th Beijing Conference and Exhibition on Instrumental Analysis (BCEIA 2021)-Shanghai Ruifu Chemical Co., Ltd. participated in the exhibition

The 19th Beijing Conference and Exhibition on Instrumental Analysis (BCEIA 2021) was held on September 27-29, 2021 at China International Exhibition Center (Tianzhu New Hall), Beijing. Adhering to...
The 3rd China International Biological & Chemical Pharmaceutical Industry Conference

The 3rd CMC-China 2021 Time: September 29-30, 2021 Exhibition Venue: C-D Hall, Suzhou International Expo Center, Suzhou City, JIangsu Province, China. Synergy of Centralized China’s Drug Volume-ba...
Pfizer's Novel COVID-19 Oral Antiviral Treatment Candidate Reduced Risk Of Hospitalization Or Death By 89% In Interim Analysis Of Phase 2/3 EPIC-HR Study

Friday, November 05, 2021 – 06:45am PAXLOVID™ (PF-07321332; ritonavir) was found to reduce the risk of hospitalization or death by 89% compared to placebo in non-hospitalized high-risk adult...

2022.06.02 02:56:19
2022.04.28 17:34:17
2022.02.22 19:23:38
2022.01.16 10:14:24
2021.12.31 11:25:58
2021.12.12 21:57:46

related search